Allison is Associate Editorial Director for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®. She joined AJMC® in 2017. She produces and oversees written, video, and podcast content across several disease states and issues surrounding value-based care and health policy.
She has an MPA from New York University. You can connect with Allison on LinkedIn.
Health Coverage Losses From Medicaid Work Requirements Are Unavoidable, Report Says
Rules around Medicaid work requirements can’t be fixed in such a way that would allow states to implement them without the negative effects of people losing health coverage, according to a report from the Center on Budget and Policy Priorities.
Severe Dyspnea Influences COPD Treatment Response, Confirms Benefit of Combination Therapy
When to begin maintenance therapy for patients with chronic obstructive pulmonary disease (COPD) with either a single drug, or a combination of long-acting bronchodilators, is not always clear. A new study looking at whether baseline symptomatic status influences response to treatment suggests that patients with more severe dyspnea benefit more from a combination of tiotropium/olodaterol than tiotropium alone.
How Are ACOs Using Segmentation to Manage High-Need, High-Cost Patients?
A recent report by The Commonwealth Fund found no consistent set of subgroups for high-need, high-cost patients managed by accountable care organizations (ACOs), but it did suggest methods by which segmenting the sickest and most costly patients could help drive improved care outcomes.
CVS Health CEO Outlines How Aetna Deal Will Benefit Customers
The chief executive officer and president of CVS Health said the integration of CVS and Aetna is well underway—even while it complies with a US district court that is reviewing the deal—more than a month after the acquisition closed.
ResMed Highlights Digital Health at JP Morgan Conference
Chronic obstructive pulmonary disease is one of the world’s top drivers of chronic disease burdens, the chief executive officer of ResMed told the JP Morgan Healthcare Conference, as he explained the company’s strategy to help meet unmet needs using digital connectivity and data analytics.
Digital Health Promises Remain Unfulfilled for High-Need, High-Cost Populations
This week, companies are showcasing digital health at conferences in Las Vegas and San Francisco, but when it comes to alleviating disease burden or the cost of care for vulnerable populations, the promise of digital health is not yet fulfilled, according to a study published in Health Affairs.
COPD Exacerbations Tied to Increased Risks for Patients Who Also Have CAD
A recent study looking at the impact of recent exacerbations of chronic obstructive pulmonary disease (COPD) on hospitalized patients who also have coronary artery disease (CAD) found that COPD was was independently associated with additional risks of complications after percutaneous coronary intervention.
Vaccination Cuts Risk of Severe Flu in Hospitalized Patients With COPD
Hospitalized patients with chronic obstructive pulmonary disease (COPD) who tested positive for the flu and were unvaccinated had worse death rates and more severe illness than those who were vaccinated, according to a recent study.
House Democrats Return to Power, Plan Hearings on ACA, Climate Change, Immigration Health
Wednesday marked the start of the 116th Congress, as Democrats took charge of the House of Representatives for the first time since 2011, and the new chairman of the Energy and Commerce Committee announced 3 hearings about the Affordable Care Act (ACA), climate change, and the Trump administration’s immigration policies.
Federal ACA Ruling to Be Appealed by Coalition of California, Democratic-Led States
As expected, California and 16 other states defending the Affordable Care Act (ACA) in a federal lawsuit announced they will appeal last month’s ruling by a Texas judge that declared the ACA unconstitutional.
Allowing HRAs for Short-Term Health Plans Would Undermine Markets, Insurers Say
The health insurance industry cautioned the Trump administration against allowing health reimbursement accounts (HRAs) to be used to purchase short-term limited duration health plans, in comments submitted regarding a proposed rule change.
Researchers Improve Knowledge of PCOS With Discovery of 3 More Genes
Polycystic ovary syndrome (PCOS) affects 10% of women, but it is often misdiagnosed or missed entirely by physicians. Now, researchers have identified the genetic underpinnings of the syndrome, including 3 new loci, a causal link to depression, and a male phenotype for PCOS.
No Difference Found in Smokers With COPD Trying Different Cessation Techniques
Long-term nicotine replacement therapy (LT-NRT) provides 1 way for smokers with chronic obstructive pulmonary disease (COPD) to try to quit, but does not result in greater rates of cessation or harm reduction, according to a recently published study.
Understanding Which Risk Factors for Osteoporosis Can Change
Which risk factors of osteoporosis can be modified, and which cannot? With osteoporosis causing more than 9 million fractures globally, understanding how to prevent it can reduce this growing threat to a rapidly aging population, researchers recently reported.
Examining ED Antibiotic Trends in Acute Exacerbations of COPD
Current guidelines for chronic obstructive pulmonary disease (COPD) call for using antibiotics in the emergency department (ED) when presented with acute exacerbations of COPD (AECOPD). A recent study sought to determine the rate at which patients with AECOPD are treated with antibiotics and also looked at the proportions of antibiotic classes prescribed, trends of antibiotic treatment, and identified independent predictors of antibiotic therapy.
Analysis Shows Benefit of Abemaciclib in Women With Worse Prognosis
A recent study of abemaciclib, a cyclindependent kinase 4 and 6 inhibitor for metastatic breast cancer, found that it helped all women with hormone receptor–positive, human epidermal growth factor receptor 2–negative disease, and that it was particularly beneficial in women with a worse prognosis.
Report Assesses Degree of Alignment Between ASCO, ESMO Oncology Frameworks
A joint assessment comparing the results of value frameworks created by the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO) found that the frameworks produce comparable measures of the clinical benefits of new cancer therapies in roughly two-thirds of more than 100 drug comparisons examined.
Patients With Mild to Moderate COPD Differ Widely in Respiratory Symptoms
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease, and patients can differ markedly in their rate of lung function decline and frequency of exacerbations. A recent study sought to determine what proportion of between-individual variability in symptoms can be explained by lung function versus all other observable characteristics.